Children’s Oncology Group: Long-Term Follow-Up Guidelines After Pediatric HCT

The Children’s Oncology Group (COG) has updated its Long-Term Follow-Up Guidelines for survivors of childhood, adolescent, and young adult cancer, including those undergoing autologous or allogeneic hematopoietic cell transplantation (HCT) for malignant and non-malignant diseases. The COG recommendations are organized by organ systems and include accompanying evidence grades. The recommendations, available at, were developed by a COG task force review of more than 800 articles from the medical literature on the subject of childhood cancer and HCT survivorship, including 586 original research articles.

Chow EJ, et al. Biol Blood Marrow Transplant

Related Resources